Drug profile · INN
parecoxib
DYNASTAT
parecoxib (DYNASTAT) is a cyclooxygenase-2 inhibitor.
EMA: approved Musculo-skeletal system (M01) M01AH04
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — parecoxib
- Class
- Musculo-skeletal system (M01)
- Route
- —
- Patents
- 0
- Programs
- 5
- Data quality
- 0.83
Quick answer
parecoxib (DYNASTAT) is a cyclooxygenase-2 inhibitor.
Key facts
INN parecoxib
Brand DYNASTAT
Mechanism Cyclooxygenase-2 inhibitor
Target Prostaglandin G/H synthase 2
Therapeutic class Musculo-skeletal system (M01)
ATC code M01AH04
Mechanism of action
Cyclooxygenase-2 inhibitor
Primary target: Prostaglandin G/H synthase 2
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is parecoxib?
parecoxib (DYNASTAT) is a cyclooxygenase-2 inhibitor.
What is the brand name for parecoxib?
DYNASTAT is a marketed brand name for parecoxib. Check FDA Drugs@FDA for the current US label holder and prescribing information.